Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer

Breast Cancer Research and Treatment

Volumn 136, Issue 3, 2012, Pages 789-794

  Jehn, C F ^a   Flath, B ^b   Strux, A ^a   Krebs, M ^a   Possinger, K ^a   Pezzutto, A ^a   Luftner D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Hämatologisch onkologische Praxis Altona ^*  (Germany)

Author keywords

Anxiety; Depression; Interleukin 6; Karnofsky performance status; Metastatic breast cancer

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFLAMMATION; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MOOD DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING TEST; TUMOR GROWTH; AGED; ANXIETY; BLOOD; BREAST TUMOR; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MIDDLE AGED; PATHOLOGY; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANXIETY; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-6; KARNOFSKY PERFORMANCE STATUS; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 84878760702     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2311-2     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
2. Costa D, Mogos I, Toma T (1985) Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand Suppl 320:85-92
3. Stoudemire A, Thompson TL (1983) Medication noncompliance: systematic approaches to evaluation and intervention. Gen Hosp Psychiatr 5(4):233-239
4. Koenig HG, Shelp F, Goli V, Cohen HJ, Blazer DG (1989) Survival and health care utilization in elderly medical inpatients with major depression. J Am Geriatr Soc 37(7):599-606
5. Fisch M (2004) Treatment of depression in cancer. J Natl Cancer Inst Monogr 32:105-111
6. Ashbury FD, Findlay H, Reynolds B, McKerracher K (1998) A Canadian survey of cancer patients' experiences: are their needs being met? J Pain Symptom Manag 16(5):298-306
7. Van't Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59(3):280-293
8. Rabe-Jablonska J, Bienkiewicz W (1994) Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV - options book. Psychiatr Pol 28(2):255-268
9. Katon W, Sullivan MD (1990) Depression and chronic medical illness. J Clin Psychiatr 51(Suppl):3-11
10. Aapro M, Cull A (1999) Depression in breast cancer patients: the need for treatment. Ann Oncol 10(6):627-636
11. Jenkins R, Bebbington P, Brugha T, et al. (2003) British Psychiatric Morbidity Survey. Int Rev Psychiatr 15(1-2):14-18
12. Cassileth BR, Lusk EJ, Hutter R, Strouse TB, Brown LL (1984) Concordance of depression and anxiety in patients with cancer. Psychol Rep 54(2):588-590
13. Danzer K (1993) The new education for the care of the well and the ill may start. Osterr Krankenpfl 46(2):8-10
14. Dentino AN, Pieper CF, Rao MK, et al. (1999) Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 47(1):6-11
15. Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77(6):1690-1694
16. Sluzewska A, Rybakowski J, Bosmans E, et al. (1996) Indicators of immune activation in major depression. Psychiatr Res 64(3):161-167
17. Musselman DL, Miller AH, Porter MR, et al. (2001) Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatr 158(8):1252-1257
18. Karnofsky DA, Burchenal JH (1950) Present status of clinical cancer chemotherapy. Am J Med 8(6):767-788
19. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
20. Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP (2004) Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101(2):404-411
21. Herrmann C (1997) International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. J Psychosom Res 42(1):17-41
22. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361-370
23. Moorey S, Greer S, Watson M, et al. (1991) The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatr 158:255-259
24. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington
25. Flower L, Humphries SE, Mohamed-Ali V, et al. (2000) Effects of sample handling on the stability of interleukin-6, tumor necrosis factor-a and leptin. Cytokine 12:1712-1716
26. Noyes R, Kathol RG, Debelius-Enemark P, et al. (1990) Distress associated with cancer as measured by illness distress scale. Psychosomatics 31:321-330
27. Massie MJ, et al. (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32:57-71
28. Pierce BL, Ballard-Barbash R, Berstein L, et al. (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27:3437-3444
29. Salgado R, Junius S, Benoy I, et al. (2003) Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103:642-646
30. Zhang GJ, Adachi I, et al. (1999) Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19:1427-1432
31. Mantovani A, Allavena P, Sica A, et al. (2008) Cancer-related inflammation. Nature 454:436-444
32. Chiang AC, Massague J (2008) Molecular basis of metastasis. N Engl J Med 359:2814-2823
33. Timpson NJ, Lawlor DA, Harbord RM, et al. (2005) C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366:1954-1959
34. Ford DE, Erlinger TP, et al. (2004) Depression and C-reactive protein in US adult: data from the third National Health and Nutrition Examination Survey. Arch Intern Med 164:1010-1014
35. Banks J, Marmot M, Oldfield Z, et al. (2006) Disease and disadvantage in the United States and in England. JAMA 295:2037-2045